Thoratec Corp $32.13

down -0.42


25/7/2014 04:00 PM  |  NASDAQ : THOR  
Industries : Health Services / Medical Instruments & Supplies
Get Trend Analysis Icon Get THOR Trend Analysis - it has underperformed the S&P 500 by 17%

Partner Headlines

  1. THORATEC

    IBD
  2. Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark ...

    Benzinga
  3. Mid-Morning Market Update: Markets Rise; Hertz Global To Spin Off Equipment ...

    Benzinga
  4. Thoratec Offers Added Info Regarding HeartMate II LVAS Pocket System Controller

    Benzinga
  5. After-Hours Movers: BV, SWHC, AVAV, CTIC Moving Higher, HCI, BOBE, CHEF, ...

    Benzinga
  6. Earnings Scheduled For February 4, 2014

    Benzinga
  7. Stocks End Mixed In Half A Session; WisdomTree Climbs

    IBD
  8. Stocks Open In Upward Drift; Thoratec Tanks On Study Results

    IBD
  9. Canaccord Genuity Comments on Recent Journal Manuscripts Related to Thoratec ...

    Benzinga
  10. Stocks Hitting 52-Week Highs

    Benzinga
  11. UPDATE: Canaccord Genuity Upgrades Thoratec Corporation Following Solid ...

    Benzinga
  12. Benzinga's Top Upgrades

    Benzinga
  13. UPDATE: Goldman Sachs Upgrades Thoratec on Good Upside Potential

    Benzinga
  14. Benzinga's Top Upgrades

    Benzinga
  15. UPDATE: Credit Suisse Upgrades Thoratec on Positive Sales Forecast

    Benzinga
  16. Industry Themes: Top Stocks Residing In Weak Groups

    IBD
  17. Thoratec Announces Approval for HeartMate II in Japan

    Benzinga
  18. UPDATE: Goldman Sachs Upgrades Thoratec Corporation to CL-Buy, Raises PT

    Benzinga
  19. Thoratec Laboratories Corporation (THOR) CEO Gerhard F Burbach sells 11,6 ...

    GuruFocus
  20. Stocks Hold Modest Gains; Stratasys Breaks Out

    IBD
  21. Thoratec Corp. Reports Operating Results (10-Q)

    GuruFocus
  22. Thoratec Corporation (THOR) VP of Finance, Interim CFO Roxanne Oulman sells ...

    GuruFocus
  23. UPDATE: Oppenheimer Maintains Outperform on Thoratec, $42 PT

    Benzinga
  24. Thoratec Reports Mixed Q2; Abiomed Waits In Wings

    IBD
  25. Earnings Scheduled For August 1, 2012

    Benzinga
  26. Thoratec's Pump Keeps Hearts Beating Longer

    IBD
  27. Thoratec Corp. (THOR) CEO Gerhard F Burbach sells 37,500 Shares

    GuruFocus
  28. Baxter Tops Q2 Estimates, Guides Q3 Profit Low

    IBD
  29. Benzinga's Top Upgrades

    Benzinga
  30. Health Care Sector Wrap

    FoxBusiness
  31. Thoratec Corp. (THOR) CEO Gerhard F Burbach sells 7,222 Shares

    GuruFocus
  32. Top Industries Firing On Only Half Their Cylinders

    IBD
  33. Medical Sector Shows Muscle With SXC Health, Cerner

    IBD
  34. UPDATE: Oppenheimer Maintains Outperform Rating, Raises PT for Thoratec

    Benzinga
  35. Benzinga's After Hours Earnings Movers

    Benzinga
  36. UPDATE: Goldman Sachs Raises Target to $36 on Thoratec

    Benzinga
  37. Thor Industries Beats Q2 Estimates

    Benzinga
  38. Notable Put Options Activity in Thoratec

    Benzinga
  39. Thoratec Corp. Reports Operating Results (10-K)

    GuruFocus
  40. UPDATE: Barrington Research Raises Price Target on Thoratec to $38

    Benzinga
  41. Barrington Research Maintains Thoratec at Outperform, Raises PT from $36 ...

    Benzinga
  42. Rodman & Renshaw Raises Thoratec PT To $42, Maintains Market Outperform

    Benzinga
  43. UPDATE: Piper Jaffray Upgrades Thoratec to Overweight

    Benzinga
  44. Goldman Sachs Maintains Thoratec at Neutral, Raises PT from $33 to $34

    Benzinga
  45. Piper Jaffray Upgrades Thoratec from Neutral to Overweight, Raises PT from ...

    Benzinga
  46. UPDATE: Canaccord Lowers Target to $31 on Thoratec

    Benzinga
  47. Auriga's Thoratec Preparing to Overcome Competitive Hurdle

    Benzinga
  48. Thoratec

    IBD
  49. Thoratec Corp Does not Expect FDA Letter will Materially Impact Company's ...

    Benzinga
Trading Center